» Articles » PMID: 22262402

Human Papillomavirus-16 E5 Protein: Oncogenic Role and Therapeutic Value

Overview
Publisher Springer
Date 2012 Jan 21
PMID 22262402
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infection occurs through sexual route, and the virus infects mucosal and cutaneous epithelial cells. Inside the cell, the viral DNA replicates extrachromosomally. HPV is the major cause of cervical cancer worldwide. HPVs infecting mucosal epithelial cells are sub-grouped into low-risk or high-risk by virtue of them causing benign warts or cancer, respectively. The early oncoproteins of HPV, namely E4, E5, E6 and E7, are known to contribute to tumorigenesis. The roles and functions of HPV E6 and E7 have been thoroughly studied over the years. However, limited studies have been done on E5 regarding its intracellular functions.

Conclusions: This review attempts to discuss the positive role of HPV16 E5 in the form of therapeutic target for cervical cancer, as well as its role in modulation of several intracellular signalling pathways leading to transformed phenotype of the host cell.

Citing Articles

Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer.

Kan X, Zhou Z, Liu L, Aiskikaer R, Zou Y Heliyon. 2025; 11(3):e42055.

PMID: 39916829 PMC: 11800076. DOI: 10.1016/j.heliyon.2025.e42055.


Role of HPV16 E1 in cervical carcinogenesis.

Baedyananda F, Sasivimolrattana T, Chaiwongkot A, Varadarajan S, Bhattarakosol P Front Cell Infect Microbiol. 2022; 12:955847.

PMID: 35967849 PMC: 9368317. DOI: 10.3389/fcimb.2022.955847.


It Takes Two to Tango: A Review of Oncogenic Virus and Host Microbiome Associated Inflammation in Head and Neck Cancer.

McKeon M, Gallant J, Kim Y, Das S Cancers (Basel). 2022; 14(13).

PMID: 35804891 PMC: 9265087. DOI: 10.3390/cancers14133120.


Development of HPV E5 and E7 peptides-based vaccines predicted by immunoinformatics tools.

Namvar A, Panahi H, Agi E, Bolhassani A Biotechnol Lett. 2020; 42(3):403-418.

PMID: 31915962 PMC: 7087594. DOI: 10.1007/s10529-020-02792-6.


Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.

Lorenz F, Ellinger C, Kieback E, Wilde S, Lietz M, Schendel D Hum Gene Ther. 2017; 28(12):1158-1168.

PMID: 28950731 PMC: 5737719. DOI: 10.1089/hum.2017.122.


References
1.
Hafner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, Runnebaum I . Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene. 2007; 27(11):1610-7. DOI: 10.1038/sj.onc.1210791. View

2.
Foy K, Liu Z, Phillips G, Miller M, Kaumaya P . Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo. J Biol Chem. 2011; 286(15):13626-37. PMC: 3075707. DOI: 10.1074/jbc.M110.216820. View

3.
Wentzensen N, Vinokurova S, von Knebel Doeberitz M . Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004; 64(11):3878-84. DOI: 10.1158/0008-5472.CAN-04-0009. View

4.
Motoyama S, Ladines-Llave C, Luis Villanueva S, Maruo T . The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J Med Sci. 2004; 50(1-2):9-19. View

5.
Kim K, Jeon Y, Park I, Kim J, Park N, Kang S . Cyclooxygenase-2 expression in cervical intraepithelial neoplasia. Ann N Y Acad Sci. 2009; 1171:111-5. DOI: 10.1111/j.1749-6632.2009.04724.x. View